Work

Sphingosine Kinase Inhibitors as Maintenance Therapy of Glioblastoma After Ceramide-Induced Response.

Year: 2016

Type: article

Source: PubMed

Authors: Laura A Sordillo, Peter P Sordillo, Lawrence Helson

Institution: SignPath Pharma (United States)

Language: English

Topic: Sphingolipid Metabolism and Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2412004106

FWCI: 1.921

Cites: 140

Cited by: 32

Related to: 10